Market Overview

Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of Tetraphase Pharmaceuticals, Inc. Investors (TTPH)


National law firm Glancy
Prongay & Murray LLP
("GPM") announces that it has filed a class
action lawsuit in the United States District Court for the Southern
District of New York on behalf of persons and/or entities that: a)
acquired Tetraphase Pharmaceuticals, Inc. ("Tetraphase" or the
"Company") (NASDAQ:TTPH) securities pursuant and/or traceable to the
Company's allegedly false and/or misleading registration statement and
prospectus issued in connection with the Company's July 2017 secondary
public offering ("SPO" or the "Offering"); and/or, b) acquired
Tetraphase securities between March 8, 2017 and February 13, 2018,
inclusive (the "Class Period"). Plaintiff pursues claims against the
Defendants, under the Securities Act of 1933 (the "Securities Act") and
the Securities Exchange Act of 1934 (the "Exchange Act").

Tetraphase investors are hereby notified that they have 60 days from
the date of this notice
to move the Court to serve as lead plaintiff
in this action.

If you are a shareholder who suffered a loss, click here to

The complaint filed in this class action alleges that throughout the
Class Period, Defendants made materially false and/or misleading
statements, as well as failed to disclose material adverse facts about
the Company's business, operations, and prospects. Specifically,
Defendants failed to disclose: (1) Tetraphase was increasing the patient
enrollment in its IGNITE3 trial from 1,000 patients to 1,200 patients to
meet the trial's primary endpoints (within the 10% non-inferiority
margin); (2) The enrollment of more patients in the trial indicated that
the existing population was inadequate to meet the trial's primary
endpoints; and (3) that, as a result of the foregoing, Defendants'
statements about Tetraphase's business, operations, and prospects, were
materially false and/or misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter:

If you purchased Tetraphase securities in connection with the Offering
and/or during the Class Period, you may move the Court no later than 60
days from the date of this notice
to ask the Court to appoint you as
lead plaintiff. To be a member of the Class you need not take any action
at this time; you may retain counsel of your choice or take no action
and remain an absent member of the Class. If you wish to learn
more about this action, or if you have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East,
Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at
888-773-9224, by email to,
or visit our website at
If you inquire by email please include your mailing address, telephone
number and number of shares purchased.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

View Comments and Join the Discussion!